D.E. Shaw & Co’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-27,118
Closed -$273K 4099
2021
Q2
$273K Buy
+27,118
New +$273K ﹤0.01% 3136